Could shedding assets spell a breakthrough for troubled GE?

Amy Scott Feb 25, 2019
HTML EMBED:
COPY

Could shedding assets spell a breakthrough for troubled GE?

Amy Scott Feb 25, 2019
HTML EMBED:
COPY

General Electric today announced the sale of its biopharmaceutical business for more than $21 billion dollars. The buyer is Danaher Corporation, which happens to have been previously run by GE chief executive Larry Kulp, who served as chief executive at Danaher between 2001 and 2015. The move is part of an ongoing restructuring aimed at paying down GE’s massive debt load and focusing on core industries the company is invested in, such as aviation and power.

Click the audio player above to hear the full story.

There’s a lot happening in the world.  Through it all, Marketplace is here for you. 

You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible. 

Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.